Industry Insight
Information, Observation & Analysis
Many years after the first products were introduced in the late 1990s, the need for fibrin sealants continues to increase.
Antibiotics are the most commonly prescribed drugs worldwide. But now, widespread antimicrobial resistance caused by environments, hosts and overmedication may soon be the demise of these "wonder drugs."
What are the true causes of the obesity epidemic that now affects more than one-third of people globally? And, do the measures thought to prevent obesity really work?
While support and resources are accessible to kids with Autism and their parents, families must prepare for children reaching adulthood, when resource availability changes and depends on a number of factors.
Studies are shedding light on this long-misunderstood and devastating condition that may soon have approved treatments to help prolong cancer patients’ lives.
HBV infection is still widely prevalent globally, but eradication could be achieved through efforts to raise awareness and find cures for the disease.
With staggering growth in the number of people addicted to and dying from opioids, government, the medical community and recovery programs are working to turn the tide.
This pervasive little-understood illness is finally getting the notice it deserves, with current attention focusing on better understanding and prevention.
The U.S. market for IVIG continues to grow well over 5 percent annually. What is driving the market demand?
Gene therapy is the one remaining therapeutic option for treating severe combined immunodeficiency by correcting it at its most fundamental genetic level.
Advancements in stem cell therapy may soon eliminate surgeries and cure disease, but first, the debate between two different schools of thought concerning how best to proceed needs to be resolved.
New extended half-life products represent a powerful new tool for improving the care and quality of life for persons with hemophilia.